Medicine and Dentistry
Percutaneous Coronary Intervention
100%
ST Segment Elevation Myocardial Infarction
92%
Rapamycin
75%
Myocardial Infarction
74%
Cardiogenic Shock
58%
Drug-Eluting Stent
56%
Stent Thrombosis
44%
Revascularization
41%
Primary Percutaneous Coronary Intervention
39%
Diabetes
38%
Diabetes Mellitus
37%
Hazard Ratio
36%
Optical Coherence Tomography
36%
Intravascular Ultrasound
35%
Coronary Artery Disease
34%
Umirolimus
32%
Everolimus
30%
Acute Heart Infarction
26%
Coronary Angiography
25%
Patient with Diabetes
23%
Zotarolimus
22%
Angiography
22%
COVID-19
22%
Target Lesion
20%
Target Lesion Revascularization
20%
Acute Coronary Syndrome
19%
Fractional Flow Reserve
19%
Heart Death
18%
Non ST Segment Elevation Myocardial Infarction
18%
Major Adverse Cardiac Event
16%
Odds Ratio
15%
Disease
15%
Cardiovascular System
14%
Coronary Artery
13%
Stable Angina Pectoris
13%
Ischemic Heart Disease
13%
Out of Hospital Cardiac Arrest
13%
Apoplexy
12%
Paclitaxel
12%
Stenosis
12%
Cohort Analysis
11%
In-Stent Restenosis
11%
Atrial Fibrillation
11%
Restenosis
11%
All Cause Mortality
10%
Noninferiority Trial
10%
Bleeding
10%
Cause of Death
10%
Thorax Pain
9%
Randomized Controlled Trial
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
80%
ST Segment Elevation Myocardial Infarction
61%
Rapamycin
60%
Stent Thrombosis
45%
Coronary Artery Disease
37%
Umirolimus
34%
Cardiogenic Shock
33%
Acute Heart Infarction
24%
Heart Death
23%
Diabetes Mellitus
23%
Everolimus
20%
Disease
19%
Ischemic Heart Disease
15%
Cardiovascular Disease
14%
Cerebrovascular Accident
12%
All Cause Mortality
11%
Noninferiority Trial
11%
Non ST Segment Elevation Myocardial Infarction
11%
Major Adverse Cardiac Event
11%
Stable Angina Pectoris
10%
Out of Hospital Cardiac Arrest
10%
Antiplatelet
9%
Zotarolimus
9%
Acute Coronary Syndrome
9%
Placebo
9%
CD34 Antibody
9%
Cardiovascular Risk
9%
Cohort Study
8%
Stenosis
8%
Brain Ischemia
8%
Randomized Clinical Trial
8%
Bleeding
7%
Atrial Fibrillation
7%
Paclitaxel
7%
Clopidogrel
7%
Cause of Death
6%
Congestive Heart Failure
6%
Mortality Rate
6%
Coronary Artery Atherosclerosis
6%
Biological Marker
6%
Observational Study
5%
Adverse Event
5%
In-Stent Restenosis
5%
Randomized Controlled Trial
5%
Nursing and Health Professions
Percutaneous Coronary Intervention
27%
ST Segment Elevation Myocardial Infarction
21%
Stent
19%
Confidence Interval
16%
Cardiogenic Shock
13%
Revascularization
13%
Coronary Angiography
13%
Drug Eluting Coronary Stent
12%
Clinical Outcome
11%
Heart Infarction
11%
Rapamycin
11%
Coronary Artery Disease
9%
Diabetes Mellitus
8%
Acute Heart Infarction
7%
Patient with Diabetes
7%
Hazard Ratio
6%
Umirolimus
6%
Computed Tomographic Angiography
5%
Stent Thrombosis
5%
